Asia Pacific Vaginal Health Probiotic Supplement Market
Description
Asia-Pacific vaginal health probiotic supplement market Size
Asia-Pacific vaginal health probiotic supplement market was US$ 122.65 million in 2024 and expected to reach up to US$ 272.40 million in 2032 growing at a CAGR of 10.6% during the forecasting period (2025-2032).
Women's concern for intimate and vaginal health is increasingly observed in supplement trends, notably probiotics designed for feminine wellbeing. Notable breakthroughs include the clinically proved Lactobacillus rhamnosus GR-1 and L. reuteri RC-14 strains, which have showed promise in lowering bacterial vaginosis and urinary tract infections. Gummies, chewables and suppositories are among the new formulations available to women, providing more practical and palate-friendly delivery options. These advances have been widely documented to improve probiotic survival and precision targeting.
Vaginal Health Probiotic Supplements Industry Trends and Strategic Insights
• Chinadominates the market in the market, capturing the largest revenue share of 35.10% in 2024.
• By type, oral supplements are projected to experience the largest market, registering a significant 68.68% in 2024.
Market Size and Future Outlook
• 2024 Market Size: US$122.65 Million
• 2032 Projected Market Size: US$272.40 Million
• CAGR (2025-2032):10.6%
• Largest Market: China
• Fastest Market: India
Market Dynamics
Clinical Validation of Probiotics for Maternal & Vaginal Health
Growing scientific validation of probiotics’ role in maternal and vaginal health is transforming the Asia-Pacific dietary supplement landscape. In South Korea, health functional foods (HFF), which include probiotic products, reached a production value of approximately US$ 2.08 billion in 2021, a 19.8% increase over the previous year. Probiotics comprised 14.7% of this segment, growing 25.6% in value, signaling robust consumer trust in these formulations.
The Indian probiotics market has nearly doubled over five years to reach INR 2,070 crore by 2025, with a 22% annual growth rate in May 2025, according to PharmaTrac data, underscoring escalating consumer interest and demand. The prevalence of traditional fermented foods, rich in natural probiotics, in cultures like Japan and South Korea supports the market’s foundation. Koreans consumed nearly 2 million metric tons of kimchi in 2021, averaging 88 grams per person per day, ensuring consistent probiotic intake in diets and fostering familiarity with such ingredients.
Segment Analysis
Asia-Pacific vaginal health probiotic supplementsmarket is segmented based on form, application, end-userand country.
Oral Supplements Lead Asia-Pacific Vaginal Health Probiotic Market Due to Ease of Use and Consumer Preference
Asia-Pacific vaginal health probiotic supplements market for oral supplements was US$ 84.23 million in 2024 and is expected to reach US$ 191.02 million by 2032, growing with a CAGR of 10.9% between 2025 and 2032.
The region is witnessing rapid growth in demand for oral probiotic supplements targeting vaginal health, driven by shifting consumer health priorities, government-led maternal programs and innovations from global and regional supplement brands. Women’s health is emerging as a strong pillar of the probiotic supplements sector, reflecting both preventive healthcare trends and lifestyle-driven interest in multi-benefit nutrition.
One of the strongest indicators of this demand is the steady growth in dietary supplement adoption across Asia. According to the Ministry of Health, Labour and Welfare in Japan, supplement usage among women in their 20s and 30s increased by nearly 12% between 2017 and 2022, with probiotics and beauty-related formulations ranking among the most popular categories. In Australia, the Therapeutic Goods Administration reported that in 2022 more than 50% of women aged 18–49 used complementary medicines, including probiotics, at least once in the past year. This demonstrates both the high awareness of supplements and the readiness for probiotic formulations designed for reproductive health and wellness.
Topical Supplements are Gaining Traction Due to Convenience and Fast-Acting Benefits
The demand trajectory is further reinforced by demographic and maternal health trends. The World Bank reports that India recorded around 23 million live births in 2022, the highest globally, while China reported about 9.6 million births in 2022. With such a large maternal base, supplements aimed at pregnancy and postpartum recovery are critical. Oral vaginal probiotics, particularly those linked to digestive and immune health, are positioned as supportive solutions for women during and after pregnancy. Antenatal and postnatal visits across Asia-Pacific are steadily increasing, giving healthcare providers consistent opportunities to introduce such supplements as part of preventive maternal care.
A significant milestone for the industry was the May 2023 launch of TruBiotics Women’s Probiotics by PanTheryx. The line included TruBiotics Women’s Capsules formulated with Bifidobacterium animalis BB-12, Lactobacillus reuteri RC-14 and L. rhamnosus GR-1 to support digestive, vaginal and bone health. In addition, TruBiotics Women’s Sugar-Free Gummies with Collagen were developed using Bacillus subtilis DE111, cranberry extract, collagen, biotin and vitamin C to address urinary, skin and hair wellness alongside vaginal health. A supporting consumer survey revealed that 60% of women are becoming more proactive about health management, but less than 30% feel adequately prepared to manage evolving changes in their bodies.
Regional Penetration
China Holds Major Share in Asia-Pacific Vaginal Health Probiotics Market Driven by High Awareness and Advanced Healthcare Infrastructure
China vaginal health probiotic supplements market was valued at US$ 43.05 million in 2024 and is estimated to reach US$ 95.61 million by 2032, growing at a CAGR of 10.6% during the forecast period from 2025-2032. The demand for vaginal health probiotic supplements in China is underpinned primarily by the high prevalence of gynecological conditions, particularly vaginitis, among women of reproductive age. Official surveys conducted in China have consistently shown that vaginal infections remain one of the most common gynecological complaints. For instance, a large-scale public health survey covering over 37,000 women across multiple provinces reported a vaginitis prevalence of around 32 percent, with bacterial vaginosis, vulvovaginal candidiasis and trichomonas infection as the dominant subtypes. The burden of disease was highest among women in their mid-30s to early 50s, an age group that is both health-conscious and more likely to purchase supplements.
In July 2024, A recent prospective controlled pilot study from Jiangxi, China, evaluated the effectiveness of Lactobacillus crispatus chen-01 in women with high-risk HPV infection. One hundred women were enrolled and randomly assigned to either a placebo group or a probiotic treatment group receiving intravaginal transplantation of L. crispatus chen-01. After six months, results showed that probiotic treatment significantly reduced HPV viral load, enhanced clearance rates and alleviated vaginal inflammation without notable adverse reactions. Microbiome sequencing confirmed that L. crispatus chen-01 helped restore vaginal microbial balance. The study highlights the link between disrupted vaginal microbiota and persistent HPV infection, as reduced Lactobacillus populations are associated with higher risk of cervical disease. Since HPV vaccines do not cover all high-risk strains and no effective therapies exist for women already infected, this research positions vaginal probiotics as a promising, safe intervention for preventing progression to cervical cancer.
India Captures Growing Share Fueled by Rising Women’s Health Awareness and Expanding Access to Supplements
The demand for vaginal health probiotic supplements in India stems from the widespread prevalence of vaginal infections among women. According to the World Health Organization (WHO), around 25–30% of women globally experience some form of vaginal infection during their lifetime, with bacterial vaginosis (BV) and yeast infections being the most frequent. India mirrors this global trend, as gynecological outpatient data from institutions such as the All India Institute of Medical Sciences (AIIMS) and state-level health surveys consistently show high rates of reproductive tract infections among women. These conditions not only cause discomfort and disruption to daily life but, when untreated, can lead to serious complications such as pelvic inflammatory disease, adverse pregnancy outcomes and infertility. Such clinical realities underscore the need for preventive and safe solutions like probiotics that can restore and maintain a balanced vaginal microbiome.
In India, conversations around women’s intimate health have historically been restricted due to cultural stigma. However, over the past decade, there has been a notable shift, with growing awareness campaigns by the Ministry of Health and Family Welfare (MoHFW) under the National Reproductive and Child Health Programme. These initiatives, combined with the increased visibility of women’s health issues on social media platforms, have created an environment where women are more willing to seek preventive health solutions. Younger, urban women in particular are showing greater acceptance of nutraceuticals and natural products. Probiotic supplements, being drug-free and positioned as natural microbiome balancers, fit well within this cultural shift toward self-care and preventive health.
Consumer Analysis
Asia-Pacific vaginal health probiotic supplements market is witnessing strong growth, fueled by rising health consciousness among women. Daily intake patterns highlight deep commitment, with an IFIC survey showing 35% of women consume probiotics once daily and 20% multiple times a day. Together, daily users make up 55% of the market, while another 27% use them a few times per week, demonstrating sustained engagement.
Smaller segments, 2% once a week, 9% a few times per month and 6% less than once a month, represent occasional users who are open to integrating probiotics into their lifestyles. Women show clear preferences for familiar formats: 55% consume yogurt, 37% take regular probiotics, 22% rely on fermented foods and 8% choose synbiotics. This mix indicates both habitual and exploratory consumption patterns.
Similarly, nutritional supplement use is more common among adults aged 19 and over (47.3%) than among children and youth (38.5%). Women are more likely than men to take supplements, especially those aged 51–70, where 65.1% of women use them compared to 42.5% of men. Social media and influencers play a key role in shaping perceptions, educating women and driving the adoption of new products. Consumers are increasingly seeking personalized solutions tailored to vaginal health, menopause and overall feminine wellness
Competitive Landscape
Asia-Pacific vaginal health probiotic supplement market is highly fragmented, with global pharmaceutical giants and regional wellness brands competing for share. Bayer’s Canesten leverages its established trust in feminine care to anchor its position. Leading ingredient suppliers like AB-Biotics and Kaneka Corporation hold significant B2B share by providing clinically-studied, proprietary strains to various manufacturers.
Regional consumer health leaders, including Himalaya Wellness, Swisse and Biome Australia, command strong brand loyalty through extensive retail distribution. Emerging DTC-focused brands like Lemme and HealthyHey Nutrition are capturing niche segments with targeted digital marketing, intensifying competition in this rapidly growing market.
Key Developments
• In September 2023, AB-BIOTICS has partnered with China’s Wonderlab to launch Shape100, featuring its clinically proven probiotic blend AB-LIFE®. This collaboration combines AB-BIOTICS’s R&D expertise with Wonderlab’s strong distribution and market presence, targeting cholesterol reduction, weight management and metabolic health. The product debuted at Vitafoods Europe 2025, gaining strong recognition. This alliance exemplifies a strategic Sino-European model for expanding probiotics in China’s fast-growing dietary supplement market.
• In January 2024, Lemme launched a capsule version of its bestselling Lemme Purr gummies, expanding its lineup of women’s health products. The new capsules, clinically formulated to support vaginal pH balance, odor control, taste and overall vaginal and urinary tract health, follow high demand and multiple sell-outs of the gummy version.
Why Choose DataM?
• Data-Driven Insights: Dive into detailed analyses with granular insights such as pricing, market shares and value chain evaluations, enriched by interviews with industry leaders and disruptors.
• Post-Purchase Support and Expert Analyst Consultations: As a valued client, gain direct access to our expert analysts for personalized advice and strategic guidance, tailored to your specific needs and challenges.
• White Papers and Case Studies: Benefit quarterly from our in-depth studies related to your purchased titles, tailored to refine your operational and marketing strategies for maximum impact.
• Annual Updates on Purchased Reports: As an existing customer, enjoy the privilege of annual updates to your reports, ensuring you stay abreast of the latest market insights and technological advancements. Terms and conditions apply.
• Specialized Focus on Emerging Markets: DataM differentiates itself by delivering in-depth, specialized insights specifically for emerging markets, rather than offering generalized geographic overviews. This approach equips our clients with a nuanced understanding and actionable intelligence that are essential for navigating and succeeding in high-growth countries.
• Value of DataM Reports: Our reports offer specialized insights tailored to the latest trends and specific business inquiries. This personalized approach provides a deeper, strategic perspective, ensuring you receive the precise information necessary to make informed decisions. These insights complement and go beyond what is typically available in generic databases.
Target Audience 2024
• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies
Asia-Pacific vaginal health probiotic supplement market was US$ 122.65 million in 2024 and expected to reach up to US$ 272.40 million in 2032 growing at a CAGR of 10.6% during the forecasting period (2025-2032).
Women's concern for intimate and vaginal health is increasingly observed in supplement trends, notably probiotics designed for feminine wellbeing. Notable breakthroughs include the clinically proved Lactobacillus rhamnosus GR-1 and L. reuteri RC-14 strains, which have showed promise in lowering bacterial vaginosis and urinary tract infections. Gummies, chewables and suppositories are among the new formulations available to women, providing more practical and palate-friendly delivery options. These advances have been widely documented to improve probiotic survival and precision targeting.
Vaginal Health Probiotic Supplements Industry Trends and Strategic Insights
• Chinadominates the market in the market, capturing the largest revenue share of 35.10% in 2024.
• By type, oral supplements are projected to experience the largest market, registering a significant 68.68% in 2024.
Market Size and Future Outlook
• 2024 Market Size: US$122.65 Million
• 2032 Projected Market Size: US$272.40 Million
• CAGR (2025-2032):10.6%
• Largest Market: China
• Fastest Market: India
Market Dynamics
Clinical Validation of Probiotics for Maternal & Vaginal Health
Growing scientific validation of probiotics’ role in maternal and vaginal health is transforming the Asia-Pacific dietary supplement landscape. In South Korea, health functional foods (HFF), which include probiotic products, reached a production value of approximately US$ 2.08 billion in 2021, a 19.8% increase over the previous year. Probiotics comprised 14.7% of this segment, growing 25.6% in value, signaling robust consumer trust in these formulations.
The Indian probiotics market has nearly doubled over five years to reach INR 2,070 crore by 2025, with a 22% annual growth rate in May 2025, according to PharmaTrac data, underscoring escalating consumer interest and demand. The prevalence of traditional fermented foods, rich in natural probiotics, in cultures like Japan and South Korea supports the market’s foundation. Koreans consumed nearly 2 million metric tons of kimchi in 2021, averaging 88 grams per person per day, ensuring consistent probiotic intake in diets and fostering familiarity with such ingredients.
Segment Analysis
Asia-Pacific vaginal health probiotic supplementsmarket is segmented based on form, application, end-userand country.
Oral Supplements Lead Asia-Pacific Vaginal Health Probiotic Market Due to Ease of Use and Consumer Preference
Asia-Pacific vaginal health probiotic supplements market for oral supplements was US$ 84.23 million in 2024 and is expected to reach US$ 191.02 million by 2032, growing with a CAGR of 10.9% between 2025 and 2032.
The region is witnessing rapid growth in demand for oral probiotic supplements targeting vaginal health, driven by shifting consumer health priorities, government-led maternal programs and innovations from global and regional supplement brands. Women’s health is emerging as a strong pillar of the probiotic supplements sector, reflecting both preventive healthcare trends and lifestyle-driven interest in multi-benefit nutrition.
One of the strongest indicators of this demand is the steady growth in dietary supplement adoption across Asia. According to the Ministry of Health, Labour and Welfare in Japan, supplement usage among women in their 20s and 30s increased by nearly 12% between 2017 and 2022, with probiotics and beauty-related formulations ranking among the most popular categories. In Australia, the Therapeutic Goods Administration reported that in 2022 more than 50% of women aged 18–49 used complementary medicines, including probiotics, at least once in the past year. This demonstrates both the high awareness of supplements and the readiness for probiotic formulations designed for reproductive health and wellness.
Topical Supplements are Gaining Traction Due to Convenience and Fast-Acting Benefits
The demand trajectory is further reinforced by demographic and maternal health trends. The World Bank reports that India recorded around 23 million live births in 2022, the highest globally, while China reported about 9.6 million births in 2022. With such a large maternal base, supplements aimed at pregnancy and postpartum recovery are critical. Oral vaginal probiotics, particularly those linked to digestive and immune health, are positioned as supportive solutions for women during and after pregnancy. Antenatal and postnatal visits across Asia-Pacific are steadily increasing, giving healthcare providers consistent opportunities to introduce such supplements as part of preventive maternal care.
A significant milestone for the industry was the May 2023 launch of TruBiotics Women’s Probiotics by PanTheryx. The line included TruBiotics Women’s Capsules formulated with Bifidobacterium animalis BB-12, Lactobacillus reuteri RC-14 and L. rhamnosus GR-1 to support digestive, vaginal and bone health. In addition, TruBiotics Women’s Sugar-Free Gummies with Collagen were developed using Bacillus subtilis DE111, cranberry extract, collagen, biotin and vitamin C to address urinary, skin and hair wellness alongside vaginal health. A supporting consumer survey revealed that 60% of women are becoming more proactive about health management, but less than 30% feel adequately prepared to manage evolving changes in their bodies.
Regional Penetration
China Holds Major Share in Asia-Pacific Vaginal Health Probiotics Market Driven by High Awareness and Advanced Healthcare Infrastructure
China vaginal health probiotic supplements market was valued at US$ 43.05 million in 2024 and is estimated to reach US$ 95.61 million by 2032, growing at a CAGR of 10.6% during the forecast period from 2025-2032. The demand for vaginal health probiotic supplements in China is underpinned primarily by the high prevalence of gynecological conditions, particularly vaginitis, among women of reproductive age. Official surveys conducted in China have consistently shown that vaginal infections remain one of the most common gynecological complaints. For instance, a large-scale public health survey covering over 37,000 women across multiple provinces reported a vaginitis prevalence of around 32 percent, with bacterial vaginosis, vulvovaginal candidiasis and trichomonas infection as the dominant subtypes. The burden of disease was highest among women in their mid-30s to early 50s, an age group that is both health-conscious and more likely to purchase supplements.
In July 2024, A recent prospective controlled pilot study from Jiangxi, China, evaluated the effectiveness of Lactobacillus crispatus chen-01 in women with high-risk HPV infection. One hundred women were enrolled and randomly assigned to either a placebo group or a probiotic treatment group receiving intravaginal transplantation of L. crispatus chen-01. After six months, results showed that probiotic treatment significantly reduced HPV viral load, enhanced clearance rates and alleviated vaginal inflammation without notable adverse reactions. Microbiome sequencing confirmed that L. crispatus chen-01 helped restore vaginal microbial balance. The study highlights the link between disrupted vaginal microbiota and persistent HPV infection, as reduced Lactobacillus populations are associated with higher risk of cervical disease. Since HPV vaccines do not cover all high-risk strains and no effective therapies exist for women already infected, this research positions vaginal probiotics as a promising, safe intervention for preventing progression to cervical cancer.
India Captures Growing Share Fueled by Rising Women’s Health Awareness and Expanding Access to Supplements
The demand for vaginal health probiotic supplements in India stems from the widespread prevalence of vaginal infections among women. According to the World Health Organization (WHO), around 25–30% of women globally experience some form of vaginal infection during their lifetime, with bacterial vaginosis (BV) and yeast infections being the most frequent. India mirrors this global trend, as gynecological outpatient data from institutions such as the All India Institute of Medical Sciences (AIIMS) and state-level health surveys consistently show high rates of reproductive tract infections among women. These conditions not only cause discomfort and disruption to daily life but, when untreated, can lead to serious complications such as pelvic inflammatory disease, adverse pregnancy outcomes and infertility. Such clinical realities underscore the need for preventive and safe solutions like probiotics that can restore and maintain a balanced vaginal microbiome.
In India, conversations around women’s intimate health have historically been restricted due to cultural stigma. However, over the past decade, there has been a notable shift, with growing awareness campaigns by the Ministry of Health and Family Welfare (MoHFW) under the National Reproductive and Child Health Programme. These initiatives, combined with the increased visibility of women’s health issues on social media platforms, have created an environment where women are more willing to seek preventive health solutions. Younger, urban women in particular are showing greater acceptance of nutraceuticals and natural products. Probiotic supplements, being drug-free and positioned as natural microbiome balancers, fit well within this cultural shift toward self-care and preventive health.
Consumer Analysis
Asia-Pacific vaginal health probiotic supplements market is witnessing strong growth, fueled by rising health consciousness among women. Daily intake patterns highlight deep commitment, with an IFIC survey showing 35% of women consume probiotics once daily and 20% multiple times a day. Together, daily users make up 55% of the market, while another 27% use them a few times per week, demonstrating sustained engagement.
Smaller segments, 2% once a week, 9% a few times per month and 6% less than once a month, represent occasional users who are open to integrating probiotics into their lifestyles. Women show clear preferences for familiar formats: 55% consume yogurt, 37% take regular probiotics, 22% rely on fermented foods and 8% choose synbiotics. This mix indicates both habitual and exploratory consumption patterns.
Similarly, nutritional supplement use is more common among adults aged 19 and over (47.3%) than among children and youth (38.5%). Women are more likely than men to take supplements, especially those aged 51–70, where 65.1% of women use them compared to 42.5% of men. Social media and influencers play a key role in shaping perceptions, educating women and driving the adoption of new products. Consumers are increasingly seeking personalized solutions tailored to vaginal health, menopause and overall feminine wellness
Competitive Landscape
Asia-Pacific vaginal health probiotic supplement market is highly fragmented, with global pharmaceutical giants and regional wellness brands competing for share. Bayer’s Canesten leverages its established trust in feminine care to anchor its position. Leading ingredient suppliers like AB-Biotics and Kaneka Corporation hold significant B2B share by providing clinically-studied, proprietary strains to various manufacturers.
Regional consumer health leaders, including Himalaya Wellness, Swisse and Biome Australia, command strong brand loyalty through extensive retail distribution. Emerging DTC-focused brands like Lemme and HealthyHey Nutrition are capturing niche segments with targeted digital marketing, intensifying competition in this rapidly growing market.
Key Developments
• In September 2023, AB-BIOTICS has partnered with China’s Wonderlab to launch Shape100, featuring its clinically proven probiotic blend AB-LIFE®. This collaboration combines AB-BIOTICS’s R&D expertise with Wonderlab’s strong distribution and market presence, targeting cholesterol reduction, weight management and metabolic health. The product debuted at Vitafoods Europe 2025, gaining strong recognition. This alliance exemplifies a strategic Sino-European model for expanding probiotics in China’s fast-growing dietary supplement market.
• In January 2024, Lemme launched a capsule version of its bestselling Lemme Purr gummies, expanding its lineup of women’s health products. The new capsules, clinically formulated to support vaginal pH balance, odor control, taste and overall vaginal and urinary tract health, follow high demand and multiple sell-outs of the gummy version.
Why Choose DataM?
• Data-Driven Insights: Dive into detailed analyses with granular insights such as pricing, market shares and value chain evaluations, enriched by interviews with industry leaders and disruptors.
• Post-Purchase Support and Expert Analyst Consultations: As a valued client, gain direct access to our expert analysts for personalized advice and strategic guidance, tailored to your specific needs and challenges.
• White Papers and Case Studies: Benefit quarterly from our in-depth studies related to your purchased titles, tailored to refine your operational and marketing strategies for maximum impact.
• Annual Updates on Purchased Reports: As an existing customer, enjoy the privilege of annual updates to your reports, ensuring you stay abreast of the latest market insights and technological advancements. Terms and conditions apply.
• Specialized Focus on Emerging Markets: DataM differentiates itself by delivering in-depth, specialized insights specifically for emerging markets, rather than offering generalized geographic overviews. This approach equips our clients with a nuanced understanding and actionable intelligence that are essential for navigating and succeeding in high-growth countries.
• Value of DataM Reports: Our reports offer specialized insights tailored to the latest trends and specific business inquiries. This personalized approach provides a deeper, strategic perspective, ensuring you receive the precise information necessary to make informed decisions. These insights complement and go beyond what is typically available in generic databases.
Target Audience 2024
• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies
Table of Contents
162 Pages
- 1. Methodology and Scope
- 1.1. Research Methodology
- 1.2. Research Objective and Scope of the Report
- 2. Definition and Overview
- 3. Executive Summary
- 3.1. Snippet by Form
- 3.2. Snippet by Application
- 3.3. Snippet by End-User
- 3.4. Snippet by Country
- 4. Dynamics
- 4.1. Impacting Factors
- 4.1.1. Drivers
- 4.1.1.1. Rising Consumer Awareness of the Vaginal Microbiome
- 4.1.2. Restraints
- 4.1.2.1. Regulatory Uncertainty for Microbial Ingredients
- 4.1.3. Opportunity
- 4.1.4. Impact Analysis
- 5. Industry Analysis
- 5.1. Porter's Five Forces Analysis
- 5.2. Supply Chain Analysis
- 5.3. Pricing Analysis
- 5.4. Regulatory and Tariff Analysis
- 5.5. Sustainability Analysis
- 5.6. Technological Analysis
- 5.7. DMI Opinion
- 6. By Form
- 6.1. Introduction
- 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
- 6.1.2. Market Attractiveness Index, By Form
- 6.2. Oral Supplements*
- 6.2.1. Introduction
- 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
- 6.2.3. Capsules and Tablets
- 6.2.4. Gummies
- 6.2.5. Powder
- 6.3. Topical Supplements
- 6.3.1. Vaginal Gels
- 6.3.2. Vaginal Suppositories
- 7. By Application
- 7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 7.1.2. Market Attractiveness Index, By Application
- 7.2. Bacterial Vaginosis (BV) Prevention & Treatment*
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
- 7.3. Menopause Support and Healthy Ageing
- 7.4. Infection Prevention & Vaginal Microbiome Support
- 7.5. Urinary Tract Health & Vaginal pH Balance
- 7.6. General Vaginal Health & Hygiene
- 8. By End-User
- 8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 8.1.2. Market Attractiveness Index, By End-User
- 8.2. Pre-Menopausal Women*
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
- 8.3. Peri-Menopausal Women
- 8.4. Post-Menopausal Women
- 9. By Country
- 9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
- 9.1.2. Market Attractiveness Index, By Country
- 9.2. China*
- 9.2.1. Introduction
- 9.2.2. Key Country-Specific Dynamics
- 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
- 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 9.3. India
- 9.3.1. Introduction
- 9.3.2. Key Country-Specific Dynamics
- 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
- 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 9.4. Japan
- 9.4.1. Introduction
- 9.4.2. Key Country-Specific Dynamics
- 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
- 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 9.5. South Korea
- 9.5.1. Introduction
- 9.5.2. Key Country-Specific Dynamics
- 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
- 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 9.6. Australia
- 9.6.1. Introduction
- 9.6.2. Key Country-Specific Dynamics
- 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
- 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 9.7. Rest of Asia-Pacific
- 9.7.1. Introduction
- 9.7.2. Key Country-Specific Dynamics
- 9.7.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
- 9.7.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.7.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 10. Competitive Landscape
- 10.1. Competitive Scenario
- 10.2. Market Positioning/Share Analysis
- 10.3. Mergers and Acquisitions Analysis
- 11. Company Profiles
- 11.1. AB-BIOTICS, SA*
- 11.1.1. Company Overview
- 11.1.2. Product Portfolio and Description
- 11.1.3. Financial Overview
- 11.1.4. Key Developments
- 11.2. Bayer Inc.
- 11.3. BIOME AUSTRALIA LIMITED
- 11.4. HealthyHey Nutrition
- 11.5. Himalaya Wellness Company
- 11.6. Laboratoire CCD
- 11.7. Lemme
- 11.8. Swisse Wellness Pty Ltd(LIST NOT EXHAUSTIVE )
- 12. Appendix
- 12.1. About Us and Services
- 12.2. Contact Us
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
